Value-Based Care

The new partnership between TransMed and Willowglade will provide help for the Innovative Oncology Business Solutions Triage Pathway to improve clinical decision support technology and alternative payment model reporting.
Results of a recent analysis showed that only three drug indications of six immuno-oncology agents met the durable survival threshold in the ASCO value framework.
A clinical pathway for patients with prostate cancer patients improved the implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects.
A recent research letter highlights gaps in understanding among community oncology practices of the Medicare Access and CHIP Reauthorization Act Quality Payment Program.
An investigation into a handful of high-quality, low-spending oncology practice sites offered insight into five specific attributes of high-value cancer care.
The use of a multidisciplinary management approach to head and neck cancer treatment increased the efficiency and level of care patients received.
Integrating lay navigators into a cancer care network reduced hospitalizations by 8% per quarter and accounted for $19 million in annual savings for Medicare.
The pharmacy benefits manager Express Scripts has signaled its embrace of value-based care with its announced purchase of eviCore.
The Centers for Medicare and Medicaid Services are being urged to make changes that could improve savings for patients and health care payers, as well as expand patient access to biosimilars.
Clinical pathway development needs to better take into account the patient perspective of cancer care, according to Alan Balch, PhD, in a presentation at the Clinical Pathways Congress.